570 related articles for article (PubMed ID: 17013569)
1. Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine.
Fleischer G; Dörr W
Strahlenther Onkol; 2006 Oct; 182(10):567-75. PubMed ID: 17013569
[TBL] [Abstract][Full Text] [Related]
2. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa.
Gehrisch A; Dörr W
Strahlenther Onkol; 2007 Jan; 183(1):36-42. PubMed ID: 17225944
[TBL] [Abstract][Full Text] [Related]
3. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
Dörr W; Bässler S; Reichel S; Spekl K
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):881-7. PubMed ID: 15936573
[TBL] [Abstract][Full Text] [Related]
4. Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation.
Dörr W; Reichel S; Spekl K
Radiother Oncol; 2005 Apr; 75(1):99-105. PubMed ID: 15878107
[TBL] [Abstract][Full Text] [Related]
5. Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF.
Dörr W; Heider K; Spekl K
Int J Radiat Biol; 2005 Aug; 81(8):557-65. PubMed ID: 16298937
[TBL] [Abstract][Full Text] [Related]
6. Effects of dexpanthenol with or without Aloe vera extract on radiation-induced oral mucositis: preclinical studies.
Dörr W; Schlichting S; Bray MA; Flockhart IR; Hopewell JW
Int J Radiat Biol; 2005 Mar; 81(3):243-50. PubMed ID: 16019933
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
[TBL] [Abstract][Full Text] [Related]
8. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis.
Epperly MW; Carpenter M; Agarwal A; Mitra P; Nie S; Greenberger JS
In Vivo; 2004; 18(4):401-10. PubMed ID: 15369176
[TBL] [Abstract][Full Text] [Related]
9. Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies.
Haagen J; Krohn H; Röllig S; Schmidt M; Wolfram K; Dörr W
Radiother Oncol; 2009 Sep; 92(3):472-6. PubMed ID: 19576646
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
Vujaskovic Z; Feng QF; Rabbani ZN; Samulski TV; Anscher MS; Brizel DM
Exp Lung Res; 2002; 28(7):577-90. PubMed ID: 12396250
[TBL] [Abstract][Full Text] [Related]
12. Radioprotection, pharmacokinetic and behavioural studies in mouse implanted with biodegradable drug (amifostine) pellets.
Srinivasan V; Pendergrass JA; Kumar KS; Landauer MR; Seed TM
Int J Radiat Biol; 2002 Jun; 78(6):535-43. PubMed ID: 12065057
[TBL] [Abstract][Full Text] [Related]
13. Effects of insulin-like growth factor-1 (IGF-1) and amifostine in spinal cord reirradiation.
Nieder C; Price RE; Rivera B; Andratschke N; Ang KK
Strahlenther Onkol; 2005 Nov; 181(11):691-5. PubMed ID: 16254703
[TBL] [Abstract][Full Text] [Related]
14. Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous route.
Koukourakis MI; Simopoulos C; Minopoulos G; Patlakas G; Polychronidis A; Limberis V; Romanides K; Pitiacoudis M; Manolas C
Clin Cancer Res; 2003 Aug; 9(9):3288-93. PubMed ID: 12960114
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) on radiation-induced mouse urinary bladder dysfunction.
Jaal J; Dörr W
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):528-33. PubMed ID: 17869665
[TBL] [Abstract][Full Text] [Related]
16. Modulation of radiation-induced oral mucositis (mouse) by selective inhibition of β1 integrin.
Albert M; Schmidt M; Cordes N; Dörr W
Radiother Oncol; 2012 Aug; 104(2):230-4. PubMed ID: 22841020
[TBL] [Abstract][Full Text] [Related]
17. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
[TBL] [Abstract][Full Text] [Related]
18. Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.
Mangoni M; Yue X; Morin C; Violot D; Frascogna V; Tao Y; Opolon P; Castaing M; Auperin A; Biti G; Barritault D; Vozenin-Brotons MC; Deutsch E; Bourhis J
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1242-50. PubMed ID: 19545790
[TBL] [Abstract][Full Text] [Related]
19. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application.
Kouloulias VE; Kouvaris JR; Pissakas G; Mallas E; Antypas C; Kokakis JD; Matsopoulos G; Michopoulos S; Mystakidou K; Vlahos LJ
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):486-93. PubMed ID: 15890591
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of systemic dermatan sulfate treatment in a preclinical model of radiation-induced oral mucositis.
Gruber S; Frings K; Kuess P; Dörr W
Strahlenther Onkol; 2018 Jul; 194(7):675-685. PubMed ID: 29497792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
